AbbVie Days Payables Outstanding from 2010 to 2025

ABBV Stock  USD 202.08  1.20  0.60%   
AbbVie Days Payables Outstanding yearly trend continues to be fairly stable with very little volatility. Days Payables Outstanding will likely drop to 55.56 in 2025. During the period from 2010 to 2025, AbbVie Days Payables Outstanding regression line of quarterly data had mean square error of  732.00 and geometric mean of  64.11. View All Fundamentals
 
Days Payables Outstanding  
First Reported
2010-12-31
Previous Quarter
63.5899787
Current Value
55.56
Quarterly Volatility
26.14337396
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 B, Interest Expense of 2.9 B or Selling General Administrative of 8.3 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 99.06. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Days Payables Outstanding Growth Pattern

Below is the plot of the Days Payables Outstanding of AbbVie Inc over the last few years. It is AbbVie's Days Payables Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
Days Payables Outstanding10 Years Trend
Very volatile
   Days Payables Outstanding   
71.253.960.361.565.963.555.5-24%12%2%7%-4%-13%100%
       Timeline  

AbbVie Days Payables Outstanding Regression Statistics

Arithmetic Mean68.58
Geometric Mean64.11
Coefficient Of Variation38.12
Mean Deviation18.52
Median65.94
Standard Deviation26.14
Sample Variance683.48
Range99.1999
R-Value0.02
Mean Square Error732.00
R-Squared0.0004
Significance0.94
Slope0.11
Total Sum of Squares10,252

AbbVie Days Payables Outstanding History

2025 55.56
2024 63.59
2023 65.94
2022 61.5
2021 60.3
2020 53.99
2019 71.24

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Days Payables Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Payables Outstanding 63.59  55.56 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…